Malek Ryan, Puckett Yana, Agasthi Pradyumna
Mclaren Macomb
Orlando Health Cancer Institute, Orlando, Florida
Coarctation of the aorta is a type of congenital heart disease which is relatively common compared to the other congenital malformations with an approximate incidence of 3 cases out of 10,000 live births. This pathology is described as a narrowing or stenotic region in which blood traverses from ascending to descending aorta. Most commonly, it is present as a well defined stenotic region at the juxtaductal location. This defect is complex as it can present through the spectrum of age ranges, be associated with other congenital defects (patent ductus arteriosus, ventricular septal defect, bicuspid aortic valve, hypoplastic left heart syndrome), and carries a diffuse array of clinical case presentations. Coarctation of the aorta, first acknowledged by Morgagni in 1760, carries a poor clinical prognosis with a mean age of death at 34 years of age and a 75% mortality at a median age of 46, according to a well-documented autopsy study. Surgical intervention for coarctation of the aorta was first described in 1944. It was performed via open lateral thoracotomy by resecting the stenotic segment of the aorta with re-anastomosis of the resected ends. This intervention was found to have been associated with a high incidence of re-coarctation. This led to the next intervention, which was called patch aortoplasty technique. This technique involved an incision across the stenotic region with a prosthetic patch sutured across the incision area. This led to a reduction in re-coarctation but was met with a high incidence of aneurysmal formation in approximately 20 to 40% of cases. Another procedure was developed for the management of coarctation of the aorta. Subclavian flap aortoplasty involves incision of the left subclavian artery down to the aortic isthmus with anastomosis of this flap with the incision across the coarcted segment to increase the vessel lumen of the aortic segment. This procedure demonstrates a 23% recurrence rate with some incidence of aneurysmal formation and rarely is associated with a complication of left arm claudication with exercise. The current preferred method of surgical management of coarctation of the aorta in the majority of surgical centers in the world is the extended end to end anastomosis given its relatively low re-coarctation rate between 4% to 13%. This intervention involves clamping of the aortic arch proximally at the take-off of the subclavian artery and distal to the coarct segment. A surgical incision is made in the inferior part of the aortic arch, the coarcted portion is resected, and the end-to-end anastomosis is completed at the arch and descending aorta. An interposition graft technique is utilized in adult-sized patients and in those with a long coarcted segment of the aorta. The aorta is clamped proximally and distally to the coarcted segment, which is resected. In the place of the resected segment, a tube graft that is composed of a Dacron or aortic homograph is secured by creating two surgical anastomoses. Transcatheter based intervention utilizing balloon angioplasty of the coarcted segment was first utilized in 1982. Compared to the surgical techniques, however, there was a significantly high re-coarctation rate in infants and less pronounced rate in adolescents and adults in the long term. Further development of technology, such as covered stents, has improved outcomes. This review will address the transcatheter management of coarctation of the aorta.
主动脉缩窄是一种先天性心脏病,与其他先天性畸形相比相对常见,在每10000例活产中约有3例发病。这种病变被描述为血液从升主动脉流向降主动脉的狭窄或缩窄区域。最常见的情况是,它表现为动脉导管旁位置明确的狭窄区域。这种缺陷很复杂,因为它可在不同年龄段出现,与其他先天性缺陷(动脉导管未闭、室间隔缺损、二叶主动脉瓣、左心发育不全综合征)相关,并且有一系列不同的临床病例表现。主动脉缩窄于1760年首次被莫尔加尼确认,根据一项有充分记录的尸检研究,其临床预后较差,平均死亡年龄为34岁,46岁时的死亡率为75%。主动脉缩窄的外科手术干预最早于1944年被描述。手术通过开胸侧切口进行,切除主动脉的狭窄段并对切除端进行重新吻合。发现这种干预与再缩窄的高发生率相关。这导致了下一种干预方法,即补片主动脉成形术。该技术包括在狭窄区域做切口,并用人工补片缝合在切口区域。这使得再缩窄有所减少,但在大约20%至40%的病例中出现动脉瘤形成的高发生率。另一种用于治疗主动脉缩窄的手术方法被开发出来。锁骨下皮瓣主动脉成形术包括将左锁骨下动脉向下切开至主动脉峡部,将该皮瓣与横跨缩窄段的切口进行吻合,以增加主动脉段的血管腔。该手术的复发率为23%,有一些动脉瘤形成的发生率,并且很少与运动时左臂间歇性跛行的并发症相关。目前,世界上大多数外科中心治疗主动脉缩窄的首选手术方法是延长端端吻合术,因为其再缩窄率相对较低,在4%至13%之间。这种干预包括在锁骨下动脉起始处近端和缩窄段远端夹住主动脉弓。在主动脉弓下部做一个手术切口,切除缩窄部分,并在主动脉弓和降主动脉处完成端端吻合。对于成年患者和主动脉缩窄段较长的患者,采用介入移植技术。在缩窄段的近端和远端夹住主动脉,切除缩窄段。在切除段的位置,通过进行两个手术吻合来固定由涤纶或主动脉同种异体移植物组成的管状移植物。基于导管的介入治疗,即对缩窄段进行球囊血管成形术,于1982年首次使用。然而,与手术技术相比,婴儿的再缩窄率明显较高,青少年和成年人的长期再缩窄率则较低。技术的进一步发展,如覆膜支架,改善了治疗效果。本综述将探讨主动脉缩窄的经导管治疗。